
Ligandal
Developing new ways to deliver gene therapies and editors, such as crispr and mrna, to cells and tissues.
Employees
Enterprise value
$7—11m
Authorizing premium user...
Developing new ways to deliver gene therapies and editors, such as crispr and mrna, to cells and tissues.